clinical trial · NCT05197881
Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix
Varian, a Siemens Healthineers Company·N/A·recruiting·n = 125
Cervical Cancer by FIGO Stage 2018Varian Ethos Adaptive Radiation Therapy
brief summary
This is a single-arm, prospective, multi-center clinical trial designed to demonstrate that adaptive radiotherapy for locally advanced cervical cancer will translate into a decreased rate of acute gastrointestinal toxicity compared with the historically reported rate for non-adaptive intensity modulated radiation therapy (IMRT). The timepoint for this assessment will be at week 5 of external beam radiotherapy (EBRT) and will use the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
started
May 3, 2022
primary completion
Sep 1, 2028
completion
Sep 1, 2030
last updated
Sep 23, 2025
official title
Daily Adaptive External Beam Radiation Therapy in the Treatment of Carcinoma of the Cervix: A Prospective Trial of an Individualized Approach for Intestinal Toxicity Reduction (ARTIA-Cervix)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol